How do we help Cholangiocarcinoma patients?
We review your case and provide a list of options from available cervical cancer clinical trials close to your home as part of Massive Bio SYNERGY-AI program or Massive Bio Virtual Tumor Board solution.
We can provide a second opinion through our Virtual Tumor Board from a cholangiocarcinoma specialist. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 73 cholangiocarcinoma clinical trials that are currently recruiting patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of oncology nurses and our artificial intelligence based clinical trial matching system will find the best option for you.
A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)
Cholangiocarcinoma forms in the bile duct and consists of a group of cancer cells. This cancer type is particularly dangerous because it often spreads to the connected tubes in the small intestine, gallbladder, and liver. More often than not, it is not detected until it has spread beyond the bile duct.
Cholangiocarcinoma patients often find out when they experience jaundice, which is the yellowing of one’s eyes and skins.
Despite being difficult to treat, there are only between 2,000 and 3,000 new cases each year, making it one of the more rare cancer types.
Several risk factors have been linked to the development of cholangiocarcinoma. These include, bile duct stones and cysts, being exposed to some chemical toxins commonly used in manufacturing, and a bile duct disease (primary sclerosing cholangitis). Many of the gene mutations that occur and cause the cancerous cells to grow are formed throughout the patient’s life. Other diseases can lead to cholangiocarcinoma as well. These include hepatitis B or C, cirrhosis, irritable bowel syndrome and diabetes. Like other cancer types, excessive alcohol use, smoking, and even obesity can be attributed to the development of cholangiocarcinoma.
Learn Your Cholangiocarcinoma Clinical Trial and Treatment Options
The most common form of treatment for cholangiocarcinoma patients are surgery, liver transplant, chemotherapy, radiation therapy, photodynamic therapy, and biliary drainage. Cholangiocarcinoma is a difficult cancer type to treat, so many patients turn to clinical trials for new and innovative treatment options.
Screening methods for cholangiocarcinoma include liver function tests, tumor marker tests, examining your bile duct with a small camera, imaging tests, and a procedure to remove a sample of tissue for testing. After the cancer is found, additional testing often takes place to determine the stage of the cancer. Cholangiocarcinoma has been viewed to be more prevalent in men than women for unknown reasons.
- Intrahepatic bile duct cancers
- Perihilar bile duct cancers (Klatskin tumors)
- Distal (extrahepatic) bile duct cancers
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.